Controversy on the role of FoxP3 + regulatory T cells in fibrogenesis in chronic hepatitis C virus infections

2014 
Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci 2013;20:342–347. [6] Waghray A, Balci B, El-Gazzaz G, Kim R, Pelley R, Narayanan MK, et al. Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant 2013;27:555–561. Carlo Sposito Vincenzo Mazzaferro⇑ The Hepato-Oncology Group, Gastro-Intestinal Surgery, Liver Transplantation and Hepatology – Fondazione IRCCS Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy ⇑Corresponding author. E-mail address: vincenzo.mazzaferro@istitutotumori.mi.it JOURNAL OF HEPATOLOGY
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    16
    References
    0
    Citations
    NaN
    KQI
    []